<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39361651</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><Issue>41</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Improved deep learning prediction of antigen-antibody interactions.</ArticleTitle><Pagination><StartPage>e2410529121</StartPage><MedlinePgn>e2410529121</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2410529121</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2410529121</ELocationID><Abstract><AbstractText>Identifying antibodies that neutralize specific antigens is crucial for developing effective immunotherapies, but this task remains challenging for many target antigens. The rise of deep learning-based computational approaches presents a promising avenue to address this challenge. Here, we assess the performance of a deep learning approach through two benchmark tests aimed at predicting antibodies for the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. Three different strategies for constructing input sequence alignments are employed for predicting structural models of antigen-antibody complexes. In our initial testing set, which comprises known experimental structures, these strategies collectively yield a significant top-ranked prediction for 61% of cases and a success rate of 47%. Notably, one strategy that utilizes the sequences of known antigen binders outperforms the other two, achieving a precision of 90% in a subsequent test set of ~1,000 antibodies, balanced between true and control antibodies for the antigen, albeit with a lower recall of 25%. Our results underscore the potential of integrating deep learning methods with single B cell sequencing techniques to enhance the prediction accuracy of antigen-antibody interactions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Mu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for the Study of Systems Biology, School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AgnistaBio Inc., Palo Alto, CA 94301.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skolnick</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1877-4958</Identifier><AffiliationInfo><Affiliation>Center for the Study of Systems Biology, School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM118039</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000936">Antigen-Antibody Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000936" MajorTopicYN="Y">Antigen-Antibody Complex</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">antibody–antigen interaction</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">structure prediction</Keyword></KeywordList><CoiStatement>Competing interests statement:M.G. is a stockholder at AgnistaBio, Inc. J.S. declares no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39361651</ArticleId><ArticleId IdType="pmc">PMC11474075</ArticleId><ArticleId IdType="doi">10.1073/pnas.2410529121</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jumper J., et al. , Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8371605</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Nakajima An D., Parks J. M., Skolnick J., AF2Complex predicts direct physical interactions in multimeric proteins with deep learning. Nat. Commun. 13, 1744 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8975832</ArticleId><ArticleId IdType="pubmed">35365655</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R., et al. , Protein complex prediction with AlphaFold-Multimer. bioRxiv [Preprint] (2021). 10.1101/2021.10.04.463034 (Accessed 10 April 2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.04.463034</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek M., et al. , Accurate prediction of protein structures and interactions using a three-track neural network. Science 373, 871–876 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612213</ArticleId><ArticleId IdType="pubmed">34282049</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., et al. , Structures of the CcmABCD heme release complex at multiple states. Nat. Commun. 13, 6422 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9616876</ArticleId><ArticleId IdType="pubmed">36307425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilcu L., Denkhaus L., Brausemann A., Zhang L., Einsle O., Architecture of the Heme-translocating CcmABCD/E complex required for Cytochrome c maturation. Nat. Commun. 14, 5190 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10457321</ArticleId><ArticleId IdType="pubmed">37626034</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Nakajima An D., Skolnick J., Deep learning-driven insights into super protein complexes for outer membrane protein biogenesis in bacteria. Elife 11, e82885 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9797188</ArticleId><ArticleId IdType="pubmed">36576775</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Skolnick J., Predicting protein interactions of the kinase Lck critical to T cell modulation. Structure In press (2024).</Citation></Reference><Reference><Citation>Yin R., Pierce B. G., Evaluation of AlphaFold antibody–antigen modeling with implications for improving predictive accuracy. Protein Sci. 33, e4865 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10751731</ArticleId><ArticleId IdType="pubmed">38073135</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy K. M., Ackerman M. E., Grigoryan G., A comparison of antibody-antigen complex sequence-to-structure prediction methods and their systematic biases. bioRxiv [Preprint] (2024). 10.1101/2024.03.15.585121 (Accessed 25 March 2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.03.15.585121</ArticleId><ArticleId IdType="pmc">PMC11337930</ArticleId><ArticleId IdType="pubmed">39167052</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie K. M., et al. , Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study. Science 374, 472–478 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9302186</ArticleId><ArticleId IdType="pubmed">34554826</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., et al. , Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses. Nat. Rev. Immunol. 23, 189–199 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9514166</ArticleId><ArticleId IdType="pubmed">36168054</ArticleId></ArticleIdList></Reference><Reference><Citation>Raybould M. I. J., Kovaltsuk A., Marks C., Deane C. M., CoV-AbDab: The coronavirus antibody database. Bioinformatics 37, 734–735 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7558925</ArticleId><ArticleId IdType="pubmed">32805021</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen T. H., Boyles F., Deane C. M., Observed antibody space: A diverse database of cleaned, annotated, and translated unpaired and paired antibody sequences. Protein Sci. 31, 141–146 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8740823</ArticleId><ArticleId IdType="pubmed">34655133</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Skolnick J., New benchmark metrics for protein-protein docking methods. Proteins 79, 1623–1634 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3076516</ArticleId><ArticleId IdType="pubmed">21365685</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshita M., et al. , Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models. iScience 25, 105596 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9664764</ArticleId><ArticleId IdType="pubmed">36406861</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrioli A., Oxenius A., Single B cell technologies for monoclonal antibody discovery. Trends Immunol. 42, 1143–1158 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34743921</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., et al. , Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies. Commun. Biol. 5, 789 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9355996</ArticleId><ArticleId IdType="pubmed">35931732</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., et al. , A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman H. M., et al. , The protein data bank. Nucleic Acids Res. 28, 235–242 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102472</ArticleId><ArticleId IdType="pubmed">10592235</ArticleId></ArticleIdList></Reference><Reference><Citation>The UniProt Consortium, UniProt: A worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506–D515 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323992</ArticleId><ArticleId IdType="pubmed">30395287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Skolnick J., iAlign: A method for the structural comparison of protein-protein interfaces. Bioinformatics 26, 2259–2265 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2935406</ArticleId><ArticleId IdType="pubmed">20624782</ArticleId></ArticleIdList></Reference><Reference><Citation>Sing T., Sander O., Beerenwinkel N., Lengauer T., ROCR: Visualizing classifier performance in R. Bioinformatics 21, 3940–3941 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16096348</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey W., Dalke A., Schulten K., VMD: Visual molecular dynamics. J. Mol. Graphics 14, 33–38 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8744570</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Skolnick J., Benchmark data derived from the antibodies for the spike receptor-binding domain of SARS-CoV-2. 10.5281/zenodo.11110249. Deposited 13 August 2024.</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.11110249</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Nakajima An D., Parks J. M., Skolnick J., AF2Complex version 1.4.1. 10.5281/zenodo.13732465. Deposited 8 September 2024.</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.13732465</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>